Which Health Care Stock Belongs in Your Portfolio?

There isn’t much to choose from in Canada, but with an aging population, this may be too good an opportunity to pass up.

The Motley Fool

Health care is a sector that’s very underrepresented in Canada, with only two names in the S&P/TSX 60 index. By comparison, healthcare makes up about 12% of the S&P 500.

This is partly due to our public health care system, which eliminates the need for massive health insurance companies, so as Canadians we should be thankful. However, as investors, it presents a problem, because as populations age, healthcare companies stand to benefit immensely; it would be nice to try to take advantage of that in our portfolios.

On that note, below we take a look at Canada’s two large companies in the health care sector.

1. Valeant Pharmaceuticals

There is perhaps no Canadian company more polarizing than Valeant Pharmaceuticals (TSX: VRX)(NYSE: VRX). To the company’s credit, its shares have been on a tear recently, thanks to CEO Michael Pearson’s acquisition-first strategy. Over the past five years, the stock has returned 56% per year.

However, there are some big question marks about Valeant. The problems stem mainly from the company’s accounting, which gets very complicated due to the high level of acquisitions. In fact, the company itself reports financial measures such as “adjusted operating cash flow” and “cash earnings per share” that exclude many acquisition-related costs. On a reported basis, Valeant actually lost $2.70 per share last year. Some very smart people, such as famous short-seller Jim Chanos, are betting against the company.

There are also some very smart people who think the run won’t end. Chief among them is activist investor Bill Ackman of Pershing Square, who would become a major shareholder if Valeant’s acquisition of Allergan (NYSE: AGN) is successful. Mr. Ackman has been continually defending Valeant on television shows.

2. Catamaran

Less well-known is the pharmacy benefit manager Catamaran (TSX: CCT)(NASDAQ: CTRX). Despite being part of the S&P TSX/60, Catamaran makes all of its money in the United States, which allows the company to benefit from some very favourable trends.

One such trend is the increase in prescription drug spending as a result of the Affordable Care Act. The ACA will result in more people being covered by a health plan. This includes pharmacy benefits, as well as maximums on how much the patient has to cover for drugs out-of-pocket. Furthermore, the aging population will also drive drug spending — Americans are forecast to spend nearly $500 billion on drugs by 2020, a big increase over the $250 billion spent in 2009.

In addition, Catamaran does not have the same accounting issues as a company like Valeant, so if you’re simply looking to make a bet on the health care sector, this is the better stock of the two.

Fool contributor Benjamin Sinclair holds no positions in any of the stocks mentioned in this article. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

oil pumps at sunset
Energy Stocks

How a $25,000 TFSA Could Fund Your Retirement

Canadians can turn to the TFSA to help provide a meaningful income stream in retirement.

Read more »

Canada day banner background design of flag
Investing

3 of the Best Canadian Stocks to Buy Right Now

These three Canadian stocks are ideal for balancing wealth-creation opportunities with stability and income generation in this uncertain outlook.

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

TFSA Strategy: How to Earn $500 a Month in Tax-Free Dividend Income

Canadians can earn $500 in tax-free dividend income or another desired amount every month using a simple TFSA strategy.

Read more »

coins jump into piggy bank
Energy Stocks

Canadian Natural Resources vs. Enbridge: The Better Dividend Stock to Buy Today

Both CNQ and ENB have impressive payout records, consistently paying and increasing their dividends for decades.

Read more »

doctor uses telehealth
Dividend Stocks

TFSA Investors: This Monthly Dividend Stock Yields 7.6%

This REIT offers investors a monthly yield investors and a regular and frequent passive income stream to supplement their regular…

Read more »

shopper chooses vegetables at grocery store
Dividend Stocks

Loblaw vs. Empire: Which Grocery Stock Would I Choose for Long-Term Growth?

Both grocers benefit from repeat shoppers. I’d give Loblaw the edge for the ways it can earn more from those…

Read more »

Retirees sip their morning coffee outside.
Dividend Stocks

2 Canadian Stocks to Buy and Hold for 20 More Years

CP Rail (TSX:CP) and another outstanding Canadian stock that's more than worth holding for many decades.

Read more »

ETF is short for exchange traded fund, a popular investment choice for Canadians
Dividend Stocks

2 Top TSX ETFs to Buy and Hold in a TFSA Forever

Looking for top TSX ETFs for your TFSA? Explore how VFV and VDY combine U.S. stock exposure and Canadian dividends…

Read more »